Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Case Report

Volume 4, Number 4, August 2014, pages 115-117


Bexarotene-Induced Dyslipidemia and Central Hypothyroidism in a Patient With Sezary Syndrome

Table

Table 1. Basal and Follow-Up Biochemical Parameters of the Case
 
Analysis (normal range)Basal (before) the treatmentAt 3 monthsAt 6 monthsAt 2 years
T. cholesterol (< 200 mg/dL)463228256218
HDL cholesterol (f > 50; m > 40 mg/dL)22.939.329.539.5
Triglycerides (< 200 mg/dL)864280341167
VLDL-Chol. (mg/dL)172.85660-
LDL-Chol. (< 160 mg/dL)267133158125
TSH (0.34 - 5.6 mIU/L)0.12< 0.010.040.01
Free T4 (0.61 - 1.12 ng/dL)0.490.770.510.72
Free T3 (2.3 - 4.2 pg/mL)2.12.842.432.29